Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription 05.08.2024 4 Aliment Pharmacol Ther 3 Clin Gastroenterol Hepatol 5 Dig Dis Sci 1 Dis Colon Rectum 2 Gastroenterology 7 Inflamm Bowel Dis 2 J Crohns Colitis 1 Lancet Gastroenterol Hepatol 1 N Engl J Med 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. FEAGAN BG, Matsuoka K, Rogler G, Laharie D, et al
   Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study.
   Aliment Pharmacol Ther. 2024 Jul 31. doi: 10.1111/apt.18158.
   PubMed         Abstract available
   
   
2. SEQUIER L, Caron B, Loeuille D, Honap S, et al
   Systematic review: Methotrexate-A poorly understood and underused medication in inflammatory bowel disease.
   Aliment Pharmacol Ther. 2024 Jul 30. doi: 10.1111/apt.18194.
   PubMed         Abstract available
   
   
3. LAN Q, Guo L, Xiong Z
   Letter: Critical appraisal of biologic therapy in management of early ulcerative colitis-Addressing study limitations and the role of psychological resilience.
   Aliment Pharmacol Ther. 2024 Jul 28. doi: 10.1111/apt.18156.
   PubMed        
   
   
4. STRANDE V, Hoivik ML, Kristensen VA
   Letter: Critical appraisal of biologic therapy in early ulcerative colitis management-Addressing study limitations and the role of psychological resilience-Authors' reply.
   Aliment Pharmacol Ther. 2024 Jul 28. doi: 10.1111/apt.18187.
   PubMed        
   
   

   
   Clin Gastroenterol Hepatol

5. MAGRO F, Peyrin-Biroulet L, Sands BE, Danese S, et al
   Endoscopic, Histologic, and Composite Endpoints in Patients with Ulcerative Colitis Treated with Etrasimod [106/120 characters, including spaces].
   Clin Gastroenterol Hepatol. 2024 Jul 30:S1542-3565(24)00681.
   PubMed         Abstract available
   
   
6. ERNEST-SUAREZ K, Murguia-Favela LE, Constantinescu C, Fitzpatrick T, et al
   LIVE ROTAVIRUS VACCINATION APPEARS LOW-RISK IN INFANTS BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGICS.
   Clin Gastroenterol Hepatol. 2024 Jul 30:S1542-3565(24)00677.
   PubMed         Abstract available
   
   
7. OHARA J, Maeda Y, Ogata N, Kuroki T, et al
   Automated Neutrophil Quantification and Histological Score Estimation in Ulcerative Colitis.
   Clin Gastroenterol Hepatol. 2024 Jul 24:S1542-3565(24)00668.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

8. COHEN-MEKELBURG S, Johnson J, Paine E, Prasad MA, et al
   Assessment of Physician Needs and Access to Inflammatory Bowel Disease Specialty Care Resources in a National Integrated Health System.
   Dig Dis Sci. 2024 Jul 27. doi: 10.1007/s10620-024-08560.
   PubMed         Abstract available
   
   
9. SWAMINATHAN A, Day AS
   Measures of Gut Inflammation in Patients with Inflammatory Bowel Disease: Are Blood-Based Biomarkers Sufficient?
   Dig Dis Sci. 2024 Jul 29. doi: 10.1007/s10620-024-08567.
   PubMed        
   
   
10. SIFFLEDEEN J, Hoentjen F
    Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes First.
    Dig Dis Sci. 2024 Jul 29. doi: 10.1007/s10620-024-08580.
    PubMed        
    
    
11. HSU WC, Chen CM, Kuo CJ, Tsou YK, et al
    Upper Gastrointestinal Involvement in Crohn's Disease as an Independent Predictor of New-Onset Strictures: Insights from an Extensive Retrospective Cohort Analysis.
    Dig Dis Sci. 2024 Aug 1. doi: 10.1007/s10620-024-08577.
    PubMed         Abstract available
    
    
12. GNANAPANDITHAN K, Stuessel LG, Shen B, Mourad FH, et al
    Pelvic Radiation Therapy Increases Risk of Pouch Failure in Patients with Inflammatory Bowel Disease and Ileal Pouch.
    Dig Dis Sci. 2024 Aug 1. doi: 10.1007/s10620-024-08576.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

13. GOMAA I, Aboelmaaty S, Bhatt H, Vierkant RA, et al
    Tofacitinib Exposure Does Not Increase Postoperative Complications Among Patients With Ulcerative Colitis Undergoing Total Colectomy: A Retrospective Case-Control Study.
    Dis Colon Rectum. 2024 Aug 1. doi: 10.1097/DCR.0000000000003440.
    PubMed         Abstract available
    
    

    
    Gastroenterology

14. CAO S, Nguyen K, Ma K, Du X, et al
    Mucosal Single-Cell Profiling of Crohn's-Like Disease of the Pouch Reveals Unique Pathogenesis and Therapeutic Targets.
    Gastroenterology. 2024 Jul 29:S0016-5085(24)05284.
    PubMed         Abstract available
    
    
15. GAWEY BJ, Kane SV
    Head and Neck Pain in a Patient with Ulcerative Colitis.
    Gastroenterology. 2024 Jul 27:S0016-5085(24)05285.
    PubMed        
    
    

    
    Inflamm Bowel Dis

16. LIM SH, Gros B, Sharma E, Lehmann A, et al
    Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.
    Inflamm Bowel Dis. 2024;30:1284-1294.
    PubMed         Abstract available
    
    
17. BARNES EL, Esckilsen S, Ashburn J, Barto A, et al
    Extensive Colitis and Smoking Are Associated With Postoperative Complications Within 30 Days of Ileal Pouch-Anal Anastomosis.
    Inflamm Bowel Dis. 2024;30:1326-1333.
    PubMed         Abstract available
    
    
18. HOSSAIN M, Plietz M, Khaitov S, Sylla P, et al
    Pouch Body Anastomotic Ulcerations Are Not Associated With an Increased Risk of Pouchitis.
    Inflamm Bowel Dis. 2024;30:1423-1425.
    PubMed        
    
    
19. IKEGAMI S, Maeda K, Urano T, Mu J, et al
    Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function.
    Inflamm Bowel Dis. 2024;30:1353-1366.
    PubMed         Abstract available
    
    
20. DI MATTIA M, Sallese M, Neri M, Lopetuso LR, et al
    Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1alpha and Microbiota's Crosstalk.
    Inflamm Bowel Dis. 2024;30:1406-1418.
    PubMed         Abstract available
    
    
21. SANDS BE, Danese S, Chapman JC, Gurjar K, et al
    Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease.
    Inflamm Bowel Dis. 2024 Jul 31:izae159. doi: 10.1093.
    PubMed         Abstract available
    
    
22. REGUEIRO M, Fischer M, Bossuyt P, McGinnis K, et al
    Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study.
    Inflamm Bowel Dis. 2024 Aug 2:izae166. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

23. MUKHERJEE PK, Chauhan G, Komoroski J, Rieder F, et al
    Deciphering the Differences Between Stricturing With or Without Penetrating Crohn's Disease: One Step Closer to Solving the Puzzle.
    J Crohns Colitis. 2024 Jul 29:jjae099. doi: 10.1093.
    PubMed        
    
    
24. RAINE T, Myrelid P, Gordon H, Adamina M, et al
    ECCO Crohn's Disease Guidelines-A Personal View of the Journey from Questions to Recommendations.
    J Crohns Colitis. 2024 Jul 27:jjae107. doi: 10.1093.
    PubMed        
    
    

    
    Lancet Gastroenterol Hepatol

25. NOOR NM, Sebastian S, Parkes M, Raine T, et al
    The need for affordable, pragmatic, investigator-led clinical trials of treatment strategies in inflammatory bowel disease.
    Lancet Gastroenterol Hepatol. 2024 Jul 30:S2468-1253(24)00225.
    PubMed        
    
    

    
    N Engl J Med

26. GRIFFIN H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, et al
    Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
    N Engl J Med. 2024;391:434-441.
    PubMed         Abstract available
    
    

    
    PLoS One

27. OLSON JL, Castillo G, Palumbo A, Harrison M, et al
    A qualitative evaluation of treatment fidelity alongside a pilot trial of a novel therapy for pediatric Inflammatory Bowel Disease.
    PLoS One. 2024;19:e0292709.
    PubMed         Abstract available
    
    
28. CRISI PE, Giordano MV, Luciani A, Gramenzi A, et al
    Evaluation of the fatty acid-based erythrocyte membrane lipidome in cats with food responsive enteropathy, inflammatory bowel disease and low-grade intestinal T-cell lymphoma.
    PLoS One. 2024;19:e0307757.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.